These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31193101)

  • 21. Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs.
    Majowicz A; Nijmeijer B; Lampen MH; Spronck L; de Haan M; Petry H; van Deventer SJ; Meyer C; Tangelder M; Ferreira V
    Mol Ther Methods Clin Dev; 2019 Sep; 14():27-36. PubMed ID: 31276009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Serum rAAV Serotype-Specific Antibodies in Patients with Duchenne Muscular Dystrophy, Becker Muscular Dystrophy, Inclusion Body Myositis, or GNE Myopathy.
    Zygmunt DA; Crowe KE; Flanigan KM; Martin PT
    Hum Gene Ther; 2017 Sep; 28(9):737-746. PubMed ID: 28042944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
    Inagaki K; Fuess S; Storm TA; Gibson GA; Mctiernan CF; Kay MA; Nakai H
    Mol Ther; 2006 Jul; 14(1):45-53. PubMed ID: 16713360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of polyploid adeno-associated virus vectors for transduction enhancement and neutralizing antibody evasion.
    Chai Z; Sun J; Rigsbee KM; Wang M; Samulski RJ; Li C
    J Control Release; 2017 Sep; 262():348-356. PubMed ID: 28789965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a Chemiluminescent ELISA Method for the Detection of Total Anti-Adeno Associated Virus Serotype 9 (AAV9) Antibodies.
    Kavita U; Dai Y; Salvador L; Miller W; Adam LP; Levesque PC; Zhang YJ; Ji QC; Pillutla RC
    Hum Gene Ther Methods; 2018 Dec; 29(6):237-250. PubMed ID: 30351228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV.
    Sanftner LM; Suzuki BM; Doroudchi MM; Feng L; McClelland A; Forsayeth JR; Cunningham J
    Mol Ther; 2004 Mar; 9(3):403-9. PubMed ID: 15006607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AAV-mediated delivery of optogenetic constructs to the macaque brain triggers humoral immune responses.
    Mendoza SD; El-Shamayleh Y; Horwitz GD
    J Neurophysiol; 2017 May; 117(5):2004-2013. PubMed ID: 28202570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
    Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
    Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral Organoids: A Human Model for AAV Capsid Selection and Therapeutic Transgene Efficacy in the Brain.
    Depla JA; Sogorb-Gonzalez M; Mulder LA; Heine VM; Konstantinova P; van Deventer SJ; Wolthers KC; Pajkrt D; Sridhar A; Evers MM
    Mol Ther Methods Clin Dev; 2020 Sep; 18():167-175. PubMed ID: 32637448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
    Ulrich-Vinther M
    Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.
    Corti M; Cleaver B; Clément N; Conlon TJ; Faris KJ; Wang G; Benson J; Tarantal AF; Fuller D; Herzog RW; Byrne BJ
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):185-93. PubMed ID: 26390092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males.
    Arruda VR; Fields PA; Milner R; Wainwright L; De Miguel MP; Donovan PJ; Herzog RW; Nichols TC; Biegel JA; Razavi M; Dake M; Huff D; Flake AW; Couto L; Kay MA; High KA
    Mol Ther; 2001 Dec; 4(6):586-92. PubMed ID: 11735343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Response Mechanisms against AAV Vectors in Animal Models.
    Martino AT; Markusic DM
    Mol Ther Methods Clin Dev; 2020 Jun; 17():198-208. PubMed ID: 31970198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5
    Majowicz A; Salas D; Zabaleta N; Rodríguez-Garcia E; González-Aseguinolaza G; Petry H; Ferreira V
    Mol Ther; 2017 Aug; 25(8):1831-1842. PubMed ID: 28596114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing viral and non-viral gene transfer methods for genetic modification of porcine mesenchymal stem cells.
    Stiehler M; Duch M; Mygind T; Li H; Ulrich-Vinther M; Modin C; Baatrup A; Lind M; Pedersen FS; Bünger CE
    Adv Exp Med Biol; 2006; 585():31-48. PubMed ID: 17120775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
    Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
    J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
    Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
    J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models.
    Davidoff AM; Gray JT; Ng CY; Zhang Y; Zhou J; Spence Y; Bakar Y; Nathwani AC
    Mol Ther; 2005 Jun; 11(6):875-88. PubMed ID: 15922958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.